BeStock  
Stocks › Biotechnology › PRAX

Praxis Precision Medicines PRAX

US equityMarket cap rank #1557Biotechnology
$300.43 −$10.47 (-3.37%)
Market closed · Nov 22, 5:10 am ET · Last extended-hours $300.43 0.00%
Open$310.07
Prev close$310.90
Day range$298.54 – $314.15
Volume806.2K
Market cap$8.40B
P/E (TTM)–
Dividend yield–

PRAX Stock News

Headlines matching Praxis Precision Medicines or the PRAX ticker, most recent first.

  • Needham Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $582Market news · 24 Sep 2026 · Direct mention
  • A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $441 to $1,201Market news · 8 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $754Market news · 8 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Praxis Precision Medicines(PRAX.US), With a Forecast Between $462 to $800Market news · 7 Aug 2026 · Direct mention
  • H.C. Wainwright Sticks to Its Buy Rating for Praxis Precision Medicines (PRAX)TipRanks · 7 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $575Market news · 21 Aug 2026 · Direct mention
  • Goldman Sachs Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Raises Target Price to $575 PositiveMarket news · 20 Aug 2026 · Direct mention
  • Oppenheimer Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $650Market news · 18 Aug 2026 · Direct mention
  • Raymond James Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $945Market news · 17 Aug 2026 · Direct mention
  • LifeSci Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $719Market news · 22 Jul 2026 · Direct mention
  • Jefferies Initiates Praxis Precision Medicines(PRAX.US) With Buy Rating, Announces Target Price $447Market news · 14 Jul 2026 · Direct mention
  • Piper Sandler Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $1,200Market news · 13 Jul 2026 · Direct mention
  • RBC Capital Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $449Market news · 11 Jul 2026 · Direct mention
  • Guggenheim Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $800Market news · 30 Jun 2026 · Direct mention
  • Jefferies Maintains Praxis Precision Medicines(PRAX.US) With Buy Rating, Maintains Target Price $550Market news · 30 Jun 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on PRAX.

Sign in to join the discussion.

Scroll to Top